ArticleJournal of the American Heart Association2026
Lipidomic Markers of Tobacco Use and Cessation Associated With Cardiovascular Risk Factors: A Longitudinal Study in American Indian Individuals.
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundResearch is warranted to identify lipidomic markers longitudinally associated with tobacco smoking and cessation and examine their associations with cardiovascular risk metrics.
methodsUsing untargeted liquid chromatography-mass spectrometry, we measured 1542 lipids among 1845 American Indian individuals at 2 visits (~5.5 years apart). Information on smoking and cessation was collected using questionnaires at both visits. Using mixed-effects linear regression, we first identified lipids associated with current smoking between current and never smokers and past smoking between former and never smokers. Random effects were used to account for family relatedness and within-individual correlations across visits. We then investigated whether longitudinal changes in smoking-related lipids were associated with smoking cessation that occurred between baseline and follow-up. We examined the longitudinal associations of a lipidomic score and each lipid with various cardiovascular risk metrics.
resultsConcentrations of 126 named lipids differed between current and never smokers (false discovery rate<0.05), whereas none differed between former and never smokers. Smoking cessation during the study period was associated with a decrease in phosphatidylcholine(p-16:0/2:0)/phosphatidylcholine(o-16:1/2:0) at false discovery rate <0.05, an upregulated lipid in current smokers. At
conclusionsCurrent smoking, but not past smoking, is associated with a broad range of lipidomic markers in American Indian individuals. Longitudinal profiling reveals suggestive evidence of lipidomic markers recovering after cessation. Once validated, these findings may elucidate key lipid pathways underlying the effects of smoking and cessation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.